Skip to main content
construction release_alert
Scholars@Duke will be down for maintenance for approximately one hour starting Tuesday, 11/11 @1pm ET
cancel
Journal cover image

Drug reaction with eosinophilia and systemic symptoms in patients hospitalized with COVID-19: a case series from a large US healthcare system.

Publication ,  Journal Article
Cucka, B; Biglione, B; Zhou, L; Phillips, EJ; Bassir, F; Samarakoon, U; Rrapi, R; Chand, S; Wang, L; Alvarez-Arango, S; Blumenthal, KG; Kroshinsky, D
Published in: Br J Dermatol
October 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Br J Dermatol

DOI

EISSN

1365-2133

Publication Date

October 2022

Volume

187

Issue

4

Start / End Page

619 / 622

Location

England

Related Subject Headings

  • Humans
  • Eosinophilia
  • Drug Hypersensitivity Syndrome
  • Dermatology & Venereal Diseases
  • Delivery of Health Care
  • COVID-19
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cucka, B., Biglione, B., Zhou, L., Phillips, E. J., Bassir, F., Samarakoon, U., … Kroshinsky, D. (2022). Drug reaction with eosinophilia and systemic symptoms in patients hospitalized with COVID-19: a case series from a large US healthcare system. Br J Dermatol, 187(4), 619–622. https://doi.org/10.1111/bjd.21706
Cucka, Bethany, Bianca Biglione, Li Zhou, Elizabeth J. Phillips, Fatima Bassir, Upeka Samarakoon, Renajd Rrapi, et al. “Drug reaction with eosinophilia and systemic symptoms in patients hospitalized with COVID-19: a case series from a large US healthcare system.Br J Dermatol 187, no. 4 (October 2022): 619–22. https://doi.org/10.1111/bjd.21706.
Cucka B, Biglione B, Zhou L, Phillips EJ, Bassir F, Samarakoon U, et al. Drug reaction with eosinophilia and systemic symptoms in patients hospitalized with COVID-19: a case series from a large US healthcare system. Br J Dermatol. 2022 Oct;187(4):619–22.
Cucka, Bethany, et al. “Drug reaction with eosinophilia and systemic symptoms in patients hospitalized with COVID-19: a case series from a large US healthcare system.Br J Dermatol, vol. 187, no. 4, Oct. 2022, pp. 619–22. Pubmed, doi:10.1111/bjd.21706.
Cucka B, Biglione B, Zhou L, Phillips EJ, Bassir F, Samarakoon U, Rrapi R, Chand S, Wang L, Alvarez-Arango S, Blumenthal KG, Kroshinsky D. Drug reaction with eosinophilia and systemic symptoms in patients hospitalized with COVID-19: a case series from a large US healthcare system. Br J Dermatol. 2022 Oct;187(4):619–622.
Journal cover image

Published In

Br J Dermatol

DOI

EISSN

1365-2133

Publication Date

October 2022

Volume

187

Issue

4

Start / End Page

619 / 622

Location

England

Related Subject Headings

  • Humans
  • Eosinophilia
  • Drug Hypersensitivity Syndrome
  • Dermatology & Venereal Diseases
  • Delivery of Health Care
  • COVID-19
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences